TREATMENT OF HYPERPROLIFERATIVE DISORDERS USING CASEIN KINASE I
摘要
The invention is generally directed to compositions and methods for affecting signal transduction using the casein kinase I (CKI) gene or gene product. The invention is more specifically directed to affecting the Wnt signal pathway using the CKI gene or gene product. The invention is particularly directed to using the CKI gene or gene product to treat and diagnose cancer, particularly breast and colon cancer. CKI epsilon is the preferred species. The field of the invention is compositions and methods for modulating signal transduction using the (CKI) gene or gene products and variants thereof. The invention is more specifically directed to modulating the Wnt signal pathway using the CKI gene or gene product. The invention is particularly directed to using the CKI gene or gene product to treat and diagnose disorders mediated by the Wnt signal pathway, especially hyperproliferative disorders, particularly breast and colon cancer.
申请公布号
WO0038709(A1)
申请公布日期
2000.07.06
申请号
WO1999US31151
申请日期
1999.12.29
申请人
CHIRON CORPORATION;XU, LICEN;HARRISON, STEPHEN, D.;WILLIAMS, LEWIS, T.
发明人
XU, LICEN;HARRISON, STEPHEN, D.;WILLIAMS, LEWIS, T.